Skip to main content

Why has your vet prescribed Aservo® EquiHaler® for your horse?

Severe equine asthma is characterised by inflammation in the lungs leading to symptoms including coughing, wheezing, poor performance and struggling to breathe.1

By treating the inflammation in your horse’s lungs with Aservo® EquiHaler® and changing their environment to prevent symptoms from coming back, you are giving them the best opportunity to live a comfortable and energetic life.

treatment inflammation in the airways

Treating inflammation in the airways

Reducing inflammation in the airways is the cornerstone of equine asthma management. Reducing inflammation opens up the airways and allows your horse to breathe more comfortably. Corticosteroids are considered the most effective class of medicine in reducing inflammation in the airways.1

Aservo® EquiHaler®

Aservo® EquiHaler®

Historically, treating lower airway inflammation effectively with corticosteroids has been a challenge because of the effects these medicines can have on the rest of the body. Aservo®EquiHaler® provides effective corticosteroid treatment specifically targeted only to the lungs, allowing horses and ponies with equine asthma to breathe comfortably while reducing the risks you may have associated with giving steroids in the past.2

What makes Aservo® EquiHaler® unique?
What makes Aservo® EquiHaler® unique?
Make-treating-asthma-a-positive-experience-with-Aservo®-EquiHaler®

Make treating asthma a positive experience with Aservo® EquiHaler®

The Aservo® EquiHaler® has been created with the comfort of both horse and owner in mind. We understand that all horses are different and some more readily accept new treatments than others. Once you have watched the training module, take a look at our tips and techniques video to find even more advice on ensuring a positive introduction of the Aservo® EquiHaler® for you and your horse.

inhaleABILITY
inhaleABILITY mobile
studied in over 600 horses
studied in over 600 horses mobile

Treat with confidence

References

  1. Couetil, L.L. et al. (2016) ‘Inflammatory airway disease in horses – revised consensus statement’, Journal of Veterinary Internal Medicine, 30, pp.503-515.
  2. Lavoie, J. P. et al. (2019) 'Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction,' Equine Veterinary Journal, 51(6), pp. 779–786.
  3. Pirie, R.S. and McGorum, B.C. (2017) ‘Inhalation therapy for equine lower respiratory tract disease’, In Practice, 39, pp. 317-327.
  4. CVMP assessment report for Aservo® EquiHaler®.

 

Aservo® EquiHaler® 343 micrograms/actuation inhalation solution for horses contains ciclesonide. For the alleviation of clinical signs of severe equine asthma (formerly known as Recurrent Airway Obstruction – (RAO), Summer Pasture Associated Recurrent Airway Obstruction – (SPA-RAO)). UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746960 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email: vetenquiries@boehringer-ingelheim.com. Aservo®EquiHaler® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under licence. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: October 2023. UI-EQU-0124-2020. Use Medicines Responsibly.

Breathe Easy

There is a new way to treat severe equine asthma.

Aservo® EquiHaler® is a prescription only medicine. This site is provided as an information service for veterinary professionals and owners of horses prescribed Aservo® EquiHaler® by a Veterinary Surgeon. Please tick ‘I’m a veterinary professional’ to confirm that you are a veterinary professional (e.g. veterinary surgeon, veterinary nurse or veterinary student) or ‘My horse has been prescribed Aservo® EquiHaler®’ to continue.

Not a veterinarian? Go back to the Boehringer Ingelheim equine information page.